Jessica Matthews

1.4k total citations
29 papers, 1.1k citations indexed

About

Jessica Matthews is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Infectious Diseases. According to data from OpenAlex, Jessica Matthews has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Infectious Diseases. Recurrent topics in Jessica Matthews's work include Neuropeptides and Animal Physiology (9 papers), HIV/AIDS drug development and treatment (8 papers) and Receptor Mechanisms and Signaling (7 papers). Jessica Matthews is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), HIV/AIDS drug development and treatment (8 papers) and Receptor Mechanisms and Signaling (7 papers). Jessica Matthews collaborates with scholars based in United States, United Kingdom and Spain. Jessica Matthews's co-authors include Rebecca J. Hodge, M. Claire Holland, Murray Stewart, Robert L. Dobbins, Erika H. De Boever, Susan Walker, Mark Bush, Dennis Heyer, Alejandro J. Daniels and O. Humberto Viveros and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Jessica Matthews

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica Matthews United States 18 439 327 294 207 156 29 1.1k
H.P. Sauerwein Netherlands 16 127 0.3× 145 0.4× 16 0.1× 90 0.4× 97 0.6× 41 953
Vanessa S. Mattevi Brazil 18 110 0.3× 98 0.3× 44 0.1× 56 0.3× 77 0.5× 47 832
Tünde Farkas-Szallasi United States 11 197 0.4× 19 0.1× 138 0.5× 94 0.5× 184 1.2× 12 1.2k
David Herion United States 15 332 0.8× 65 0.2× 171 0.6× 68 0.3× 177 1.1× 20 1.8k
M Langer Germany 7 73 0.2× 25 0.1× 102 0.3× 165 0.8× 53 0.3× 19 513
Michelle A. Kendall United States 19 109 0.2× 118 0.4× 36 0.1× 222 1.1× 521 3.3× 37 1.4k
Alessandro Rossi Italy 18 238 0.5× 142 0.4× 195 0.7× 99 0.5× 18 0.1× 78 1.1k
Linda Hilsted Denmark 19 191 0.4× 391 1.2× 137 0.5× 229 1.1× 117 0.8× 54 1.0k
C Huber Austria 4 225 0.5× 37 0.1× 17 0.1× 54 0.3× 117 0.8× 5 1.0k

Countries citing papers authored by Jessica Matthews

Since Specialization
Citations

This map shows the geographic impact of Jessica Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Matthews more than expected).

Fields of papers citing papers by Jessica Matthews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Matthews. The network helps show where Jessica Matthews may publish in the future.

Co-authorship network of co-authors of Jessica Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Matthews. A scholar is included among the top collaborators of Jessica Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Matthews. Jessica Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, Rashmi, Konstantinos Angelis, Lesley Kahl, et al.. (2023). Pharmacokinetic and pharmacokinetic/pharmacodynamic characterization of the dolutegravir/rilpivirine two‐drug regimen in SWORD‐1/‐2 phase 3 studies. British Journal of Clinical Pharmacology. 89(7). 2190–2200. 2 indexed citations
2.
Rolle, Charlotte-Paige, Mezgebe Berhe, Tulika Singh, et al.. (2023). Sustained Virologic Suppression With Dolutegravir/Lamivudine in a Test-and-Treat Setting Through 48 Weeks. Open Forum Infectious Diseases. 10(3). ofad101–ofad101. 11 indexed citations
3.
Rolle, Charlotte-Paige, Mezgebe Berhe, Tulika Singh, et al.. (2021). 75. High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study. Open Forum Infectious Diseases. 8(Supplement_1). S49–S49. 1 indexed citations
5.
Mehdi, Syed, Stephen J Milan, Steven Dodd, et al.. (2019). Speech and language therapy for management of chronic cough. Cochrane Database of Systematic Reviews. 2019(7). CD013067–CD013067. 25 indexed citations
6.
Matthews, Jessica, Rickey R. Reinhardt, & Molly C. Carr. (2016). Postprandial plasma glucose effects of once-weekly albiglutide for the treatment of type 2 diabetes. Postgraduate Medicine. 128(4). 391–397. 3 indexed citations
7.
Young, Malcolm A., Jeffrey A. Wald, Jessica Matthews, Fred Yang, & Rickey R. Reinhardt. (2014). Effect of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Albiglutide. Postgraduate Medicine. 126(3). 35–46. 22 indexed citations
8.
Darpö, Börje, Meijian Zhou, Jessica Matthews, et al.. (2014). Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study. Diabetes Therapy. 5(1). 141–153. 23 indexed citations
9.
Young, Malcolm A., Jeffrey A. Wald, Jessica Matthews, et al.. (2014). Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist. Postgraduate Medicine. 126(7). 84–97. 30 indexed citations
10.
Bush, Mark, Jessica Matthews, Erika H. De Boever, et al.. (2009). Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects. Diabetes Obesity and Metabolism. 11(5). 498–505. 143 indexed citations
11.
Richman, Peter B., Steven J. Lester, Jessica Matthews, et al.. (2004). Electrocardiographic findings in Emergency Department patients with pulmonary embolism. Journal of Emergency Medicine. 27(2). 121–126. 17 indexed citations
13.
Daniels, A.J., Mary K. Grizzle, Robert P. Wiard, Jessica Matthews, & Dennis Heyer. (2002). Food intake inhibition and reduction in body weight gain in lean and obese rodents treated with GW438014A, a potent and selective NPY-Y5 receptor antagonist. Regulatory Peptides. 106(1-3). 47–54. 44 indexed citations
15.
Matthews, Jessica, Marilyn Jansen, Richard F. Cox, et al.. (1997). Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors. Regulatory Peptides. 72(2-3). 113–119. 40 indexed citations
16.
Tadepalli, Anjaneyulu S., W. Wallace Harrington, Mir A. Hashim, et al.. (1996). Hemodynamic Characterization of a Novel Neuropeptide Y Receptor Antagonist. Journal of Cardiovascular Pharmacology. 27(5). 712–718. 7 indexed citations
18.
Daniels, Alejandro J., O. Humberto Viveros, & Jessica Matthews. (1994). The Role of Extracellular Calcium in the Neuropeptide-Y-Induced Increase in Cytosolic Calcium in Human Erythroleukemic (HEL) Cells. Molecular and Cellular Neuroscience. 5(5). 466–474. 1 indexed citations
19.
Daniels, Alejandro J., Jessica Matthews, O. Humberto Viveros, & Eduardo R. Lazarowski. (1992). Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells.. Molecular Pharmacology. 41(4). 767–771. 17 indexed citations
20.
Daniels, Alejandro J., Eduardo R. Lazarowski, Jessica Matthews, & Eduardo G. Lapetina. (1989). Neuropeptide Y mobilizes intracellular Ca2+ and increases inositol phosphate production in Human Erythroleukemia Cells. Biochemical and Biophysical Research Communications. 165(3). 1138–1144. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026